Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using SW as Medical Device
- Conditions
- Diabetes Mellitus
- Interventions
- Device: SW as medical devices(comperator) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .
- Registration Number
- NCT06467903
- Lead Sponsor
- Bonmedix Holding a.s.
- Brief Summary
A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using AI medical device
- Detailed Description
A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using the SWaMD medical device and the SWaMD comparator, when evaluating the patients retinal image
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Men and women aged ≥ 40 years
- Signed informed consent
- Confirmed type 1 or 2 diabetes mellitus
- Ocular findings that do not allow retinal photography (significant nystagmus, corneal leukoma, dense cataract, hemophthalmus, etc.)
- Patient has a condition or is in a situation that, in the opinion of the investigator, may bias the results of the study, may significantly interfere with the patient's participation in the investigation, or may result in unproducible photographs of a dilated ocular fundus
- Patients with restrictions on personal freedom by administrative or legal order
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description one arm - 1000 patients, DR screening SW as medical devices(comperator) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) . SW as medical devices(investigational device) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .
- Primary Outcome Measures
Name Time Method Sensitivity and specificity 3 months The sensitivity and specificity will be calculated using the evaluation of independent masked expert (ophthalmologist) as gold standard.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Jakub Sedivy
🇨🇿Příbram, Or, Czechia